Since we found that PRMT3 plays an important role in OXA resistance, we first determined whether high PRMT3 expression, as determined by IHC staining, correlates with poor response to OXA-based HAIC in 36 cases of post-treatment surgical HCC samples. The gene discussed is PRMT3; the disease is hepatocellular carcinoma.